CD81 is a novel immunotherapeutic target for B cell lymphoma.
Vences-Catalán F, Kuo CC, Rajapaksa R, Duault C, Andor N, Czerwinski DK, Levy R, Levy S.
Vences-Catalán F, et al. Among authors: andor n.
J Exp Med. 2019 Jul 1;216(7):1497-1508. doi: 10.1084/jem.20190186. Epub 2019 May 23.
J Exp Med. 2019.
PMID: 31123084
Free PMC article.